跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,418 条关于
“DEEs”
全部
4,418
临床试验
4,123
药物
18
机构
35
资讯
242
去年
Longboard Pharmaceuticals Initiates Phase III Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Bexicaserin Shows Sustained Seizure Reduction in Developmental Epileptic Encephalopathies
去年
Longboard Pharmaceuticals Launches Phase 3 Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
2个月前
Lundbeck Completes Randomization in Landmark DEEp OCEAN Phase III Trial of Bexicaserin for Developmental and Epileptic Encephalopathies
去年
Lundbeck's Bexicaserin Shows Sustained 59% Seizure Reduction in Rare Epilepsy Extension Study
去年
Lundbeck Presents Bexicaserin Data for Developmental and Epileptic Encephalopathies at AES Annual Meeting
去年
Lundbeck to Acquire Longboard Pharmaceuticals for $2.6 Billion, Bolstering Epilepsy Pipeline
2年前
Longboard's Bexicaserin Shows Sustained Seizure Reduction in DEE Patients
去年
Lundbeck to Acquire Longboard for $2.6 Billion, Bolstering Neuro-Rare Disease Pipeline
9个月前
Lundbeck's Bexicaserin Shows Sustained Seizure Reduction in Rare Childhood Epilepsies After Two Years of Treatment
第 1 页,共 25 页
上一页
下一页